Immunovant, Inc. (IMVT) Misses Q3 EPS by 10c
Immunovant, Inc. (NASDAQ: IMVT) reported Q3 EPS of ($0.49), $0.10 worse than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Immunovant, Inc. (NASDAQ: IMVT) reported Q3 EPS of ($0.49), $0.10 worse than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.